PEPTOMYC
A Healthtech startup included in the Barcelona & Catalonia Startup Hub

PEPTOMYC
Peptomyc SL is a spin-off company of the vall d'hebron institute of oncology (vhio) and the catalan institute of research and advanced studies (icrea) based in barcelonaspain. It was founded by dr. laura soucek and dr. marie-eve beaulieu. peptomyc focuses on the discovery and translation of its proprietary drugs for cancer treatment up to the clinical demonstration of safety and efficacy and out-licensing to a larger pharmaceutical entity for their commercialization.
Industries & Technologies
Financial data
Other information
Funding
2.5M € (October 2023)
capital
Investors: EIC Fund
25.5M € (January 2022)
Minority stake unknown %
Investors: HEALTHEQUITY, ALTA LIFE SCIENCES, AURORA SCIENCE, InviierteMeSL
11.4M € (December 2020)
Minority stake unknown %
Investors: CDTI, HEALTHEQUITY, ALTA LIFE SCIENCES, AURORA SCIENCE
4.2M € (September 2017)
Minority stake unknown %
Investors: ALTAMAR (ALTA LIFE SCIENCE)
1M € (April 2016)
Minority stake unknown %
Investors: INSTITUTIONAL INVESTORS, BUSINESS ANGEL CONSORTIUM, HEALTHEQUITY SCR SA
Source: Press releases newsletters & platforms company websites annual reports & accounts regulatory body sites & stock exchanges
Other startups near startup PEPTOMYC
similar companies
Collaborators of Barcelona & Catalonia Startup Hub.
We teamed up with business associations, universities and startup incubators to create the Barcelona & Catalonia Startup Hub.